Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home Business Abris-backed Velvet CARE buys Almus

Abris-backed Velvet CARE buys Almus

by uma
0 comment


Acquisition will boost Velvet CARE’s position as the Polish market leader in paper tissue manufacturing.

Abris Capital Partners (“Abris”), the ESG transformation specialist private equity investor, has supported Velvet CARE, the largest independent tissue manufacturer in Poland, in acquiring Almus, a family-owned Polish tissue converting business.

Almus manufactures toilet paper and kitchen towels, offering high quality products in both branded and private label categories. The company has a well-invested asset base, including five modern and high-quality converting lines with a total capacity of 70,000 tonnes annually, and has been growing steadily in recent years. The acquisition will strengthen Velvet CARE’s market leadership position and boost the company’s medium and long-term growth prospects.

Tomasz Kujawa, Investment Director at Abris Capital Partners, commented:
“This investment is the next step in Velvet CARE’s ambitious consolidation of the regional market. Under the exceptional management of the Velvet CARE team, the acquisition of Almus will generate numerous synergies and further cement the company’s position as a regional champion in terms of quality, efficiency and ESG integration.”

Abris acquired Velvet CARE in 2018 with a plan to create a leading regional player in private label and branded tissue products. The company has grown strongly during Abris’ investment, with continued positive performance in 2021 and 2022 despite cost pressures and the changing geopolitical landscape.

During this period, the business has focused on production efficiency, flexibility and automation in converting, further improving its competitive positioning across all product categories. Velvet CARE has also secured foothold in the German market and established a presence in key export markets including the Czech Republic, Slovakia, the Baltics and Scandinavia. In addition, Abris is continuing to drive Velvet CARE’s eco agenda, with the aim of achieving carbon neutrality within three years.

Velvet CARE CEO Artur Pielak, added:
“We are delighted to welcome the Almus team on board, who will help us strengthen our position as Poland’s market leader in tissue products. We look forward to joining forces with Almus to offer clients best-in-class tissue products.”

The investment builds Abris’ track record in this sector, with the firm having previously invested in Pehart, a leading tissue paper producer in Romania.